IRIDEX Statistics
Total Valuation
IRIDEX has a market cap or net worth of $32.34 million. The enterprise value is $29.45 million.
| Market Cap | 32.34M |
| Enterprise Value | 29.45M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IRIDEX has 16.25 million shares outstanding. The number of shares has increased by 1.57% in one year.
| Shares Outstanding | 16.25M |
| Shares Change (YoY) | +1.57% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 19.99% |
| Owned by Institutions (%) | 20.50% |
| Float | 12.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.65 |
| Forward PS | 0.62 |
| PB Ratio | 4.99 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.39.
| Current Ratio | 1.72 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -105.40% and return on invested capital (ROIC) is -121.61%.
| Return on Equity (ROE) | -105.40% |
| Return on Assets (ROA) | -31.20% |
| Return on Capital (ROIC) | -121.61% |
| Revenue Per Employee | $449,766 |
| Profits Per Employee | -$98,595 |
| Employee Count | 111 |
| Asset Turnover | 1.42 |
| Inventory Turnover | 2.66 |
Taxes
In the past 12 months, IRIDEX has paid $116,000 in taxes.
| Income Tax | 116,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.40% in the last 52 weeks. The beta is 0.84, so IRIDEX's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -3.40% |
| 50-Day Moving Average | 2.31 |
| 200-Day Moving Average | 2.63 |
| Relative Strength Index (RSI) | 39.69 |
| Average Volume (20 Days) | 31,193 |
Short Selling Information
The latest short interest is 339,508, so 2.09% of the outstanding shares have been sold short.
| Short Interest | 339,508 |
| Short Previous Month | 317,499 |
| Short % of Shares Out | 2.09% |
| Short % of Float | 2.78% |
| Short Ratio (days to cover) | 13.80 |
Income Statement
In the last 12 months, IRIDEX had revenue of $49.92 million and -$10.94 million in losses. Loss per share was -$0.67.
| Revenue | 49.92M |
| Gross Profit | 20.33M |
| Operating Income | -10.96M |
| Pretax Income | -10.83M |
| Net Income | -10.94M |
| EBITDA | -8.78M |
| EBIT | -10.83M |
| Loss Per Share | -$0.67 |
Balance Sheet
The company has $5.42 million in cash and $2.52 million in debt, giving a net cash position of $2.90 million or $0.18 per share.
| Cash & Cash Equivalents | 5.42M |
| Total Debt | 2.52M |
| Net Cash | 2.90M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 6.49M |
| Book Value Per Share | 0.40 |
| Working Capital | 11.51M |
Cash Flow
In the last 12 months, operating cash flow was -$5.55 million and capital expenditures -$69,000, giving a free cash flow of -$5.62 million.
| Operating Cash Flow | -5.55M |
| Capital Expenditures | -69,000 |
| Free Cash Flow | -5.62M |
| FCF Per Share | -$0.35 |
Margins
Gross margin is 40.72%, with operating and profit margins of -21.95% and -21.92%.
| Gross Margin | 40.72% |
| Operating Margin | -21.95% |
| Pretax Margin | -21.69% |
| Profit Margin | -21.92% |
| EBITDA Margin | -17.58% |
| EBIT Margin | -21.69% |
| FCF Margin | -11.26% |
Dividends & Yields
IRIDEX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.57% |
| Shareholder Yield | -1.57% |
| Earnings Yield | -33.84% |
| FCF Yield | -17.37% |
Analyst Forecast
The average price target for IRIDEX is $2.00, which is 0.50% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.00 |
| Price Target Difference | 0.50% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRIDEX has an Altman Z-Score of -1.86 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.86 |
| Piotroski F-Score | 2 |